TRABECTEDIN

Basic Information

Item Value
DrugBank ID DB05109
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 23

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 hereditary site-specific ovarian cancer syndrome TxGNN Knowledge Graph
2 leiomyosarcoma TxGNN Knowledge Graph
3 familial ovarian cancer TxGNN Knowledge Graph
4 maligant granulosa cell tumor of ovary TxGNN Knowledge Graph
5 malignant non-dysgerminomatous germ cell tumor of ovary TxGNN Knowledge Graph
6 malignant Sertoli-Leydig cell tumor of ovary TxGNN Knowledge Graph
7 borderline epithelial tumor of ovary TxGNN Knowledge Graph
8 liposarcoma TxGNN Knowledge Graph
9 ovarian clear cell adenocarcinoma TxGNN Knowledge Graph
10 malignant germ cell tumor of ovary TxGNN Knowledge Graph
11 ovarian mucinous adenocarcinoma TxGNN Knowledge Graph
12 yolk sac tumor TxGNN Knowledge Graph
13 ovarian adenocarcinoma TxGNN Knowledge Graph
14 immature ovarian teratoma TxGNN Knowledge Graph
15 ovarian endometrioid adenocarcinoma TxGNN Knowledge Graph
16 ovarian small cell carcinoma TxGNN Knowledge Graph
17 primary non-gestational choriocarcinoma of ovary TxGNN Knowledge Graph
18 ovarian cancer TxGNN Knowledge Graph
19 theca steroid-producing cell malignant tumor of ovary, not further specified TxGNN Knowledge Graph
20 hereditary breast ovarian cancer syndrome TxGNN Knowledge Graph
21 malignant dysgerminomatous germ cell tumor of ovary TxGNN Knowledge Graph
22 malignant sex cord stromal tumor of ovary TxGNN Knowledge Graph
23 ovarian carcinosarcoma TxGNN Knowledge Graph

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search